SightfileU.S. market data from official filings
Companies › GERN
GERON CORP (GERN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0000886744 · EDGAR filings · Updated 2026-07-01
GERON CORP (GERN) has reported institutional ownership of 77.5%, with 255 institutional managers holding positions valued at $740.7M per the latest 13F reporting period.
Institutional ownership
77.5%
Institutional managers
255
Reported 13F value
$740.7M
Insider activity
11 trans.
−$3.42K net selling
Latest updates
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-05-27 — Current report (8-K) filed
- 2026-05-26 — Insider transaction reported (Form 4)
- 2026-05-26 — Insider transaction reported (Form 4)
- 2026-05-26 — Insider transaction reported (Form 4)
- 2026-05-26 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, GERON CORP has 255 institutional holders and institutional ownership of 77.5%.
Insider activity
Insiders reported 11 transactions (1 buys, 1 sells) across 4 reporting insiders, with a net reported value of −$3.42K.
Related companies
HARROW INC (HROW) · ARS PHARMACEUTICALS INC (SPRY) · SCHRODINGER INC (SDGR) · IRADIMED CORP (IRMD) · SOLID BIOSCIENCES INC (SLDB) · VOR BIOPHARMA INC (VOR)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-01.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-01.